382 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Pineridge Advisors LLC

Pineridge Advisors LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 382 shares of the healthcare conglomerate’s stock, valued at approximately $201,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. LFA Lugano Financial Advisors SA lifted its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Finally, O Brien Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 36.8% during the 4th quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock worth $41,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $0.18 on Friday, reaching $497.12. The company’s stock had a trading volume of 3,188,374 shares, compared to its average volume of 3,452,273. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a market capitalization of $457.54 billion, a P/E ratio of 30.39, a PEG ratio of 1.44 and a beta of 0.58. The stock has a 50-day moving average price of $493.55 and a 200-day moving average price of $506.38.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the prior year, the business earned $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.69%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on UNH. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Robert W. Baird started coverage on shares of UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price objective on the stock. Piper Sandler boosted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.